Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride treat hair loss; more research needed for other options.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

HIV can cause unusual and severe skin problems that are hard to treat.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Tooth papilla cells can help regenerate hair follicles and grow hair.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.